MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20249406

November 15, 2024

Drug Information

注射用氯诺昔康

注射剂

8mg(每瓶实装8.6mg)

化学药品

November 15, 2024

Company Information

Applicant Company

浙江省金华市东阳市江北街道猴塘社区广福东街23号总部中心B幢东楼502-1室

Manufacturing Company

湖北省潜江市章华南路特1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath